SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has ...
Moleculin Biotech (NASDAQ:MBRX) is offering 16.08M shares or pre-funded warrants and Series E warrants to purchase up to 48.24M shares at $0.37/unit. Series E warrants have a $0.37 exercise price, are ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Evaxion ...
SEATTLE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has closed its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results